Market Tracker

10/21 6:05pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

During the Trading Day
225.71 -5.62 / -2.43%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
226.00 +0.29 / +0.13%
 
Volume: 1.2K

Today’s Trading

Previous close231.33
Today’s open230.85
Day’s range221.01 - 236.95
Volume326,956
Average volume (3 months)481,799
Market cap$4.9B
Dividend yield--
Data as of 3:59pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-247.27%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book54.43

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.06+0.17%
AKRXAkorn Inc+2.28+5.84%
GRFSGrifols SA+1.16+3.65%
UTHRUnited Therapeutics ...+1.15+0.91%
Data as of 4:14pm ET, 10/21/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$1.13
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts